How many studies have been conducted on Vasodilator Stimulated Phosphoprotein?

BiohacksAI has indexed 300 PubMed studies on Vasodilator Stimulated Phosphoprotein, including 13 randomized controlled trials (RCTs). 25% of studies involve human subjects.

What are the main research areas for Vasodilator Stimulated Phosphoprotein?

The primary research domains for Vasodilator Stimulated Phosphoprotein are 🔬 Oncology, ❤️ Cardiovascular, 🦴 Bone & Joint. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Vasodilator Stimulated Phosphoprotein

An actin-associated protein expressed in platelets and various cells and tissues. It is also recognized as a substrate for CYCLIC GMP-DEPENDENT PROTEIN KINASES and CYCLIC AMP-DEPENDENT PROTEIN KINASES. It plays a role in various processes, including platelet activation and cell migration.

300+ PubMed studies analyzed · 13 RCTs · Evidence Score: 47.4

Research Domains

Vasodilator Stimulated Phosphoprotein has been studied across 18 research domains including 🔬 Oncology, ❤️ Cardiovascular, 🦴 Bone & Joint, 🔬 Inflammation, 🧘 Stress & Anxiety. The primary research focus is 🔬 Oncology with 15% of studies addressing this area.

Loading evidence profile...

This evidence profile for Vasodilator Stimulated Phosphoprotein is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.